# Progress Note 01 — Initial plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Emile Griffith (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-BX005-SYN-TD
- Date: 2005-05-05
- Fictional facility: St. Posthumous Health Center
- Fictional author: Celeste Fairbanks-Ochieng, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

## Subjective

The patient participates in this fictional visit for establishing care with his care partner for memory loss and confusion: cognitive testing, reversible causes, PTSD and depression screening with a safety assessment, falls, and the plan. **S**

## Objective

White blood cells: 6.1 10*3/uL; Hemoglobin: 14.2 g/dL; Platelets: 228 10*3/uL; Sodium: 140 mmol/L; Potassium: 4.2 mmol/L; Creatinine: 1 mg/dL; eGFR (CKD-EPI 2000): 82 mL/min/1.73 m²; Glucose: 94 mg/dL; Calcium: 9.4 mg/dL; Vitamin B12: 418 pg/mL; TSH: 2.1 mIU/L; MoCA: 22; PHQ-9: 9; PC-PTSD-5: 4; PCL-5: 41. All results are synthetic.

BP 134/80 mmHg; pulse 70 bpm; respirations 14/min; temperature 36.7 °C; oxygen saturation 98% on room air; weight 74 kg; BMI 25.6 kg/m². All vital signs are synthetic.

## Assessment

Active problems: Memory loss and confusion over about a year, worse in recent months, reported by him and his care partner: repeating stories and questions, losing the thread of conversations, mixing up days, two missed appointments, and once getting lost changing trains on a familiar route; cause to be found; Post-traumatic stress disorder, chronic, after two index events (a title fight decades ago after which his opponent died, and a severe assault thirteen years ago): nightmares, unwanted images, avoidance of fight footage, guilt and self-blame, being on guard in crowds, poor sleep; PCL-5 41; Personal history of traumatic brain injury: repetitive head impacts over 112 professional bouts, and a severe head injury in an assault thirteen years ago with months in hospital. Strengths and supports remain part of the care plan. **S**

## Medication changes

- Started: Sertraline 25 mg oral tablet, one tablet each morning **S**

## Plan

- Cognitive work-up under the Alzheimer's Association guideline: history from him and his care partner, MoCA, function, depression and PTSD screening, first-tier blood tests (blood count, metabolic panel, B12, TSH), a medicine review for anticholinergic and sedating drugs, a sleep apnea screen, hearing and vision checks, and brain MRI. Guideline: Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for specialty care (2024); Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for primary care (2024); CMID: Clinical Monitoring Intelligence Database, Non-Alzheimer's dementia and Depression/Bipolar/Mood Disorders monographs (2026) **S**
- Cognitive neurology consultation at the memory clinic to stage the impairment, weigh traumatic brain injury, traumatic encephalopathy syndrome, Alzheimer's disease, vascular disease and the effects of PTSD and depression, and choose further testing. Guideline: Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for specialty care (2024); National Institute of Neurological Disorders and Stroke Consensus Diagnostic Criteria for Traumatic Encephalopathy Syndrome (2021) **S**
- PTSD treatment by shared decision: cognitive processing therapy with the clinic psychologist, weekly for about twelve sessions, adapted for memory problems; and sertraline 25 mg each morning, raised to 50 mg after four to six weeks if tolerated, with sodium checked two weeks after starting and after the increase; benzodiazepines avoided. Guideline: VA/DoD Clinical Practice Guideline for Management of Posttraumatic Stress Disorder and Acute Stress Disorder (2023); American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults (2023) **S**
- Collaborative safety plan with warning signs, coping steps, people to call, the clinic number and the 988 Suicide & Crisis Lifeline; medicines kept by his care partner; PHQ-9 item 9 and safety reviewed at every visit. Guideline: VA/DoD Clinical Practice Guideline for Management of Posttraumatic Stress Disorder and Acute Stress Disorder (2023); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024) **S**
- Falls: STEADI assessment, physical therapy for balance and strength with a home program, and a home safety check. Guideline: CMID: Clinical Monitoring Intelligence Database, Non-Alzheimer's dementia and Depression/Bipolar/Mood Disorders monographs (2026); STEADI (Stopping Elderly Accidents, Deaths and Injuries): Clinical Resources (2024) **S**
- Measurement-based care: PCL-5 and PHQ-9 at each chronic-care visit during treatment; MoCA yearly or sooner with change; medicine review every visit. Guideline: Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for specialty care (2024); VA/DoD Clinical Practice Guideline for Management of Posttraumatic Stress Disorder and Acute Stress Disorder (2023); CMID: Clinical Monitoring Intelligence Database, Non-Alzheimer's dementia and Depression/Bipolar/Mood Disorders monographs (2026) **S**
- Advance care planning while he can take part fully: a health care agent, his values and goals of care, at the annual wellness visit. Guideline: Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for specialty care (2024); CMID: Clinical Monitoring Intelligence Database, Non-Alzheimer's dementia and Depression/Bipolar/Mood Disorders monographs (2026) **S**
